Literature DB >> 1691229

The mouse antibody response to Trichinella spiralis defines a single, immunodominant epitope shared by multiple antigens.

E Y Denkers1, D L Wassom, C J Krco, C E Hayes.   

Abstract

Immunoblot analysis was used to characterize the Trichinella spiralis L1 larval Ag recognized by antisera from T. spiralis-infected AKR/J mice. Antisera were analyzed for reactivity with crude worm extract, excretory/secretory proteins and cuticle proteins from L1 larvae. The response was biphasic; antibodies against one set of Ag were detected 13 days after infection (group I Ag), and antibodies against a different set of Ag were detected 35 days after infection (group II Ag). Excretory/secretory and cuticle proteins were recognized only by antibodies produced late in infection. The predominant isotype in day 42 antiserum was IgG1, and 80% of these IgG1 antibodies reacted with a stage-specific determinant shared by virtually all group II Ag. A mAb reactive with the shared determinant was used to purify the group II Ag from L1 larval extract. Such affinity-purified Ag were protective when used to immunize mice against subsequent infection, and T cells from infected mice proliferated when cultured with these Ag in vitro. Other mouse strains also made a strong serum antibody response to the group II Ag. We hypothesize that immune responses to the shared epitope play an important role in determining the outcome of the host-parasite interaction during infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691229

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Dominance of immunoglobulin G2c in the antiphosphorylcholine response of rats infected with Trichinella spiralis.

Authors:  P J Peters; L F Gagliardo; E A Sabin; A B Betchen; K Ghosh; J B Oblak; J A Appleton
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Identification of diagnostic antigens from Trichinella spiralis.

Authors:  W L Homan; A C Derksen; F van Knapen
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

3.  Heligmosomoides polygyrus elicits a dominant nonprotective antibody response directed against restricted glycan and peptide epitopes.

Authors:  James P Hewitson; Kara J Filbey; John R Grainger; Adam A Dowle; Mark Pearson; Janice Murray; Yvonne Harcus; Rick M Maizels
Journal:  J Immunol       Date:  2011-09-30       Impact factor: 5.422

Review 4.  Immunity to Trichinella spiralis muscle infection.

Authors:  M V Fabre; D P Beiting; S K Bliss; J A Appleton
Journal:  Vet Parasitol       Date:  2008-10-22       Impact factor: 2.738

5.  Carbohydrate epitopes on Haemonchus contortus antigens.

Authors:  H D Schallig; M A van Leeuwen
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

6.  Validation of a Western Blot for the detection of anti-Trichinella spp. antibodies in domestic pigs.

Authors:  C F Frey; M E Schuppers; K Nöckler; A Marinculić; E Pozio; U Kihm; B Gottstein
Journal:  Parasitol Res       Date:  2009-01-07       Impact factor: 2.289

7.  Interleukin-10 limits local and body cavity inflammation during infection with muscle-stage Trichinella spiralis.

Authors:  Daniel P Beiting; Susan K Bliss; Donald H Schlafer; Victoria L Roberts; Judith A Appleton
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

8.  Evaluation of Trichinella spiralis larva group 1 antigens for serodiagnosis of human trichinellosis.

Authors:  Marcela Escalante; Fernanda Romarís; Mercedes Rodríguez; Esperanza Rodríguez; José Leiro; María T Gárate; Florencio M Ubeira
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

9.  Species-specific antibody responses to the recombinant 53-kilodalton excretory and secretory proteins in mice infected with Trichinella spp.

Authors:  Isao Nagano; Zhiliang Wu; Yuzo Takahashi
Journal:  Clin Vaccine Immunol       Date:  2008-01-09

Review 10.  Secretory Products of Trichinella spiralis Muscle Larvae and Immunomodulation: Implication for Autoimmune Diseases, Allergies, and Malignancies.

Authors:  Ljiljana Sofronic-Milosavljevic; Natasa Ilic; Elena Pinelli; Alisa Gruden-Movsesijan
Journal:  J Immunol Res       Date:  2015-05-31       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.